Abstract: A pumping system pumps material or fluid, for example, downhole to perform a stimulation operation. A pumping system may comprise multiple pumps that must be powered-up in a sequence that does not overload a power source. A variable frequency drive may be coupled to a pump via a motor and may adjust the speed of the motor to control the rate of pumping of fluid from the pump. A soft-starter may be coupled to a pump via a motor to provide a constant pumping rate of fluid from the pump. A power-up sequence may be determined that provides power to the variable frequency pump and the soft-starter to power-up the corresponding motors such that the power source is not strained or overloaded. Mixing variable frequency drive driven pumps with pumps driven by a soft-starter may provide an efficient use of available power, conserve space, allow for control over a pumping rate of fluid and reduce costs.

Abstract: Provided is a mountable container including a body portion, defined by an exterior wall, at least one partition disposed within a general interior region of the body portion, wherein the at least one partition defines a first interior region and a second interior region, at least one insert disposed within the first interior region, the insert having a ramped surface with respect to a flat bottom surface of the first interior region, wherein, when the body portion is mounted to a sloped structure at a slope corresponding to a slope of the sloped structure, the ramped surface of the insert is flat with respect to a ground surface. An associated method is also provided.

Abstract: Provided is a mountable container including a body portion, defined by an exterior wall, at least one partition disposed within a general interior region of the body portion, wherein the at least one partition defines a first interior region and a second interior region, at least one insert disposed within the first interior region, the insert having a ramped surface with respect to a flat bottom surface of the first interior region, wherein, when the body portion is mounted to a sloped structure at a slope corresponding to a slope of the sloped structure, the ramped surface of the insert is flat with respect to a ground surface. An associated method is also provided.

Abstract: A pumping system pumps material or fluid, for example, downhole to perform a stimulation operation. A pumping system may comprise multiple pumps that must be powered-up in a sequence that does not overload a power source. A variable frequency drive may be coupled to a pump via a motor and may adjust the speed of the motor to control the rate of pumping of fluid from the pump. A soft-starter may be coupled to a pump via a motor to provide a constant pumping rate of fluid from the pump. A power-up sequence may be determined that provides power to the variable frequency pump and the soft-starter to power-up the corresponding motors such that the power source is not strained or overloaded. Mixing variable frequency drive driven pumps with pumps driven by a soft-starter may provide an efficient use of available power, conserve space, allow for control over a pumping rate of fluid and reduce costs.

Abstract: A job plan may be developed far in advance of actual execution of any one or more specified well servicing operations. To account for all the factors, parameters or conditions that occur at an actual well site a revised job plan may be generated that accounts for the actual site equipment available, environmental factors, one or more costs, available power source, optimal operation of equipment and any other factors. Any one or more of the factors may be weighted according to a particular physical location or other factors of the job plan. Correlating the collected, known, and actual information about equipment and a physical location allows for the generation of an optimized revised job plan that provides better utilization of equipment, including power sources, and control of costs.

Abstract: The invention provides antibodies that bind to a plurality of ?-chemokines, particularly monocyte chemotactic proteins MCP-1, MCP-2 and MCP-3. The invention also provides cells producing the antibodies, and methods of making and using the same.

Abstract: The invention provides antibodies that bind to a plurality of ?-chemokines, particularly monocyte chemotactic proteins MCP-1, MCP-2 and MCP-3. The invention also provides cells producing the antibodies, and methods of making and using the same.

Abstract: The invention provides antibodies that bind to a plurality of ?-chemokines, particularly monocyte chemotactic proteins MCP-1, MCP-2 and MCP-3. The invention also provides cells producing the antibodies, and methods of making and using the same.

Abstract: The invention provides humanized antibodies that bind to a plurality of b-chemokines, particularly monocyte chemotactic proteins MCP-1, MCP-2 and MCP-3. The invention also provides therapeutic reagents and methods of treating disorders associated with detrimental MCP activity.

Abstract: The invention provides humanized antibodies that bind to a plurality of ?-chemokines, particularly monocyte chemotactic proteins MCP-1, MCP-2 and MCP-3. The invention also provides therapeutic reagents and methods of treating disorders associated with detrimental MCP activity.

Abstract: The invention provides antibodies that bind to a plurality of ?-chemokines, particularly monocyte chemotactic proteins MCP-1, MCP-2 and MCP-3. The invention also provides cells producing the antibodies, and methods of making and using the same.

Abstract: The invention provides antibodies that bind to a plurality of ?-chemokines, particularly monocyte chemotactic proteins MCP-1, MCP-2 and MCP-3. The invention also provides cells producing the antibodies, and methods of making and using the same.

Abstract: The invention provides humanized antibodies that bind to a plurality of ?-chemokines, particularly monocyte chemotactic proteins MCP-1, MCP-2 and MCP-3. The invention also provides therapeutic reagents and methods of treating disorders associated with detrimental MCP activity.

Abstract: The invention provides antibodies that bind to a plurality of ?-chemokines, particularly monocyte chemotactic proteins MCP-1, MCP-2 and MCP-3. The invention also provides cells producing the antibodies, and methods of making and using the same.

Abstract: The invention provides humanized antibodies that bind to a plurality of b-chemokines, particularly monocyte chemotactic proteins MCP-1, MCP-2 and MCP-3. The invention also provides therapeutic reagents and methods of treating disorders associated with detrimental MCP activity.

Abstract: The invention provides antibodies that bind to a plurality of ?-chemokines, particularly monocyte chemotactic proteins MCP-1, MCP-2 and MCP-3. The invention also provides cells producing the antibodies, and methods of making and using the same.

Abstract: The invention provides antibodies that bind to a plurality of ?-chemokines, particularly monocyte chemotactic proteins MCP-1, MCP-2 and MCP-3. The invention also provides cells producing the antibodies, and methods of making and using the same.

Abstract: The invention provides antibodies that bind to a plurality of ?-chemokines, particularly monocyte chemotactic proteins MCP-1, MCP-2 and MCP-3. The invention also provides cells producing the antibodies, and methods of making and using the same.

Abstract: The invention provides antibodies that bind to a plurality of ?-chemokines, particularly monocyte chemotactic proteins MCP-1, MCP-2 and MCP-3. The invention also provides cells producing the antibodies, and methods of making and using the same.

Abstract: The invention provides humanized antibodies that bind to a plurality of b-chemokines, particularly monocyte chemotactic proteins MCP-1, MCP-2 and MCP-3. The invention also provides therapeutic reagents and methods of treating disorders associated with detrimental MCP activity.